Structures by: Torres H.
Total: 13
1-(Benzotriazol-1-ylmethyl)-5-(4-dimethylaminophenyl)-3- phenyl-4,5-dihydro-1H-pyrazole
C24H24N6
Acta Crystallographica Section E (2003) 59, 4 o517-o518
a=10.8485(2)Å b=14.4584(4)Å c=14.0433(4)Å
α=90.00° β=106.8400(10)° γ=90.00°
6-(4-fluorophenyl)-5,6-dihydrobenzimidazo[1,2-c]quinazoline
C20H14FN3
Acta Crystallographica, Section E: Structure Reports Online (2003) 59, 11 o1801-o1803
a=22.3211(8)Å b=22.3211(8)Å c=17.2220(9)Å
α=90.00° β=90.00° γ=120.00°
5-(4-Bromophenyl)-3-phenyl-1-(3-phenylpropyl)-1H-pyrazole
C24H21BrN2
Acta Crystallographica Section E (2004) 60, 3 o324-o326
a=5.67550(10)Å b=25.5102(5)Å c=26.5536(5)Å
α=90.00° β=90.00° γ=90.00°
3-methyl-1,4-diphenyl-1H-pyrazolo-(3,4-b)pyridine
C19H15N3
Acta Crystallographica Section C (2002) 58, 5 o298-o300
a=8.1392(4)Å b=8.4351(4)Å c=11.3852(6)Å
α=77.951(3)° β=81.192(2)° γ=70.681(2)°
5-(3-(4-methylphenyl)-2-propenylidene]-2,2-dimethyl-[1,3] dioxane-4,6-dione
C16H16O4
Acta Crystallographica Section C (2002) 58, 1 o39-o41
a=11.2891(3)Å b=11.4128(4)Å c=13.4504(5)Å
α=91.217(2)° β=114.640(3)° γ=113.7590(15)°
5-(3-(4-chlorophenyl)-2-propenylidene]-2,2-dimethyl-[1,3] dioxane-4,6-dione
C15H13ClO4
Acta Crystallographica Section C (2002) 58, 1 o39-o41
a=7.2648(2)Å b=7.4705(3)Å c=13.5855(6)Å
α=90.1799(13)° β=99.8452(14)° γ=109.576(3)°
2-Phenyl-5-p-tolyl-1,5,6,10b-tetrahydropyrazolo[1,5-c]quinazoline
C23H21N3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=8.5292(12)Å b=10.7291(16)Å c=11.0469(16)Å
α=109.417(2)° β=91.555(3)° γ=110.945(3)°
5-(4-Bromophenyl)-2-phenyl-1,5,6,10b-tetrahydropyrazolo[1,5-c]quinazoline
C22H18BrN3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=8.5110(2)Å b=10.7015(3)Å c=11.0357(3)Å
α=110.036(2)° β=92.1613(15)° γ=110.3276(10)°
2-(4-Chlorophenyl)-5-phenyl-1,5,6,10b-tetrahydropyrazolo[1,5-c]quinazoline
C22H18ClN3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=21.2115(3)Å b=11.1385(2)Å c=17.5948(4)Å
α=90° β=122.4270(10)° γ=90°
5-(4-Bromophenyl)-2-(4-chlorophenyl)-1,5,6,10b-tetrahydropyrazolo[1,5-c] quinazoline
C22H17BrClN3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=5.55600(10)Å b=12.2526(2)Å c=14.0827(3)Å
α=77.9230(9)° β=83.0060(8)° γ=87.8140(10)°
1,5-Bis(4-chlorophenyl)-3-(2-chloroquinolin-3-yl)pentane-1,5-dione
C26H18Cl3NO2
Acta Crystallographica Section C (2006) 62, 1 o39-o41
a=11.2405(2)Å b=18.8738(3)Å c=21.0529(3)Å
α=90.00° β=90.00° γ=90.00°
5-Chloro-3-methyl-4-[3-(4-nitrophenyl)-4,5-dihydro-1H-pyrazol-5-yl]-1-phenyl- 1H-pyrazole
C19H16ClN5O2
Acta Crystallographica Section C (2006) 62, 1 o30-o32
a=5.5055(2)Å b=11.8317(3)Å c=13.5668(4)Å
α=83.3210(17)° β=78.9560(17)° γ=86.3960(18)°
1-Benzyl-4-(4-nitrophenyl)-2,3-dihydro-1H-1,5-benzodiazepine
C22H19N3O2
Acta Crystallographica Section C (2005) 61, 6 o404-o407
a=7.3810(2)Å b=10.8016(3)Å c=22.1319(5)Å
α=90.00° β=90.00° γ=90.00°